Soluble HLA-G induces NF-κB activation in natural killer cells

Journal of Physiology and Biochemistry

Volumn 66, Issue 1, 2010, Pages 39-46

  Zidi, I ^a   Guillard, C ^a   Carosella, E D ^a   Moreau, P ^a  

^a DIF   (France)

Author keywords

HLA G; NF B; NK cells; Signal transduction

Indexed keywords

HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G5 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; SOLUBILITY;

EID: 77955101320     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-010-0005-y     Document Type: Article

References (40)

1. Carosella E, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N (2003) HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81:199-252.
2. Chang CC, Ferrone S (2003) HLA-G in melanoma: can the current controversies be solved? Semin Cancer Biol 13:361-369.
3. Clements CS, Kjer-Nielsen L, Kostenko L, Hoare HL, Dunstone MA, Moses E, Freed K, Brooks AG, Rossjohn J, McCluskey J (2005) Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 102:3360-3365.
4. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818.
5. Davies C, Bem D, Young L, Eliopoulos A (2005) NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells. Cell Signal 17:729-738.
6. El Kirwan S, Burshtyn D (2007) Regulation of natural killer cell activity. Curr Opin Immunol 19:46-54.
7. Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, Ohyanagi H, Yoshie O (2001) Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha/CCL20 in mucosal epithelial cells through NF-kappaB. Int Immunol 13:1255-1263.
8. Gronning L, Cederberg A, Miura N, Enerback S, Tasken K (2002) Insulin and TNF alpha induce expression of forkhead transcription factor gene Foxc2 in 3T3-L1 adipocytes via PI3K and ERK 1/2-dependent pathways. Mol Endocrinol 16:873-883.
9. Guillard C, Zidi I, Marcou C, Menier C, Carosella E, Moreau P (2008) Role of HLA-G in the innate immunity through the HLA-G mediated NF-kappaB activation in natural killer cells. Mol Immunol 45:419-427.
10. Jiang K, Zhong B, Gilvary D, Corliss B, Hong-Geller E, Wei S, Djeu J (2000) Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol 1:419-425.
11. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y (2001) Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 7:195-200.
12. Kanai T, Fujii T, Unno N, Yamashita T, Hyodo H, Miki A, Hamai Y, Kozuma S, Taketani Y (2001) Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 45:94-99. (Pubitemid 32111904)
13. Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman S, Kirkland J, Pothoulakis C (2006) Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 103:5207-5212.
14. Karin M, Greten FR (2005) NF-kappa B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759.
15. Le Gal F, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet J, Carosella E, Rouas-Freiss N (1999) HLA-G mediated-inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11:101-106.
16. Le Rond S, Azéma C, Krawice-Radanne I, Durrbach A, Guettier C, Carosella E, Rouas-Freiss N (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176:3266-3276.
17. Le Rond S, Le Maoult J, Créput C, Menier C, Deschamps M, Le Friec G, Amiot L, Durrbach A, Dausset J, Carosella E, Rouas-Freiss N (2004) Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol 34:649-660.
18. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98:12150-12155.
19. Mami-Chouaib F, Ameyar M, Dorothée G, Bentires-Alj M, Dziembowska M, Delhalle S, Gay F, Stancou R, Bours V, Chouaib S (2001) Effect of nuclear factor kappa B inhibition on tumor cell sensitivity to natural killermediated cytolytic function. Eur J Immunol 31:433-439.
20. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, Carosella ED, Kirszenbaum M, Guillet J (2001) A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 33:2355-2359.
21. Papazahariadou M, Athanasiadis G, Papadopoulos E, Symeonidou I, Hatzistilianou M, Castellani M, Bhattacharya K, Shanmugham L, Conti P, Frydas S (2007) Involvement of NK cells against tumors and parasites. Int J Biol Markers 22:144-153.
22. Park GM, Lee S, Park B, Kim E, Shin J, Cho K, Ahn K (2004) Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 313:606-611.
23. Paul P, Rouas-Freiss N, Moreau P, Cabestre F, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J, Morales P, Villena A, Giacomini P, Natali P, Frumento G, Ferrara G, McMaster M, Fisher S, Schust D, Ferrone S, Dausset J, Geraghty D, Carosella E (2000) HLA-G, -E, -F preworkshop: tools and protocols for analysis of non classical class I genes transcription and protein expression. Hum Immunol 61:1177-1195.
24. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME (1997) Novel inhibitors of cytokineinduced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103.
25. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4:e9.
26. Rajagopalan S, Long EO (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189:1093-1100.
27. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED (2001) HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166:5018-5026.
28. Rouas-Freiss N, LeMaoult J, Moreau P, Dausset J, Carosella ED (2003) HLA-G in transplantation: a relevant molecule for inhibition of graft rejection? Am J Transplant 3:11-16.
29. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249-5254.
30. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED (2005) HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 65:10139-10144.
31. Sebti Y, Le Friec G, Pangault C, Gros F, Drenou B, Guilloux V, Bernard M, Lamy T, Fauchet R, Amiot L (2003) Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 64:1093-1101.
32. Sebti Y, Le Maux A, Gros F, De Guibert S, Pangault C, Rouas-Freiss N, Bernard M, Amiot L (2007) Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol 138:202-212.
33. Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, Young H (1997) Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 272:30412-30420.
34. Sizemore N, Leung S, Stark G (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19:4798-4805.
35. Stagg J, Smyth M (2007) NK cell-based cancer immunotherapy. Drug News Perspect 20:155-163.
36. Ugurel S, Rebmann V, Ferrone S, TilgenW, Grosse-Wilde H, Reinhold U(2001) Soluble human leukocyte antigen-Gserum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 92:369-376.
37. Vanden BW, Plaisance S, Boone E, De Bosscher K, Schmitz M, Fiers W, Haegeman G (1998) p38 and extracellular signal-regulated kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273:3285-3290.
38. Xie C, Patel R, Wu T, Zhu J, Henry T, Bhaskarabhatla M, Samudrala R, Tus K, Gong Y, Zhou H, Wakeland E, Zhou X, Mohan C (2007) PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr. Int Immunol 19:509-522.
39. Yan WH, Fan LA (2005) Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res 15:176-182.
40. Zidi I, Guillard C, Marcou C, Krawice-Radanne I, Sangrouber D, Rouas-Freiss N, Carosella E, Moreau P (2006) Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kB inducers. Cell Mol Life Sci 63:2669-2681.